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Abstract 
Apatite Nuclei were synthesized by raising pH of simulated body fluid (SBF). The Apatite Nuclei were attached to 
the surfaces of magnetite microparticles. By the soak in SBF, hydroxyapatite was induced from the Apatite Nuclei 
and covered the whole surface area of the magnetite microparticles, and then encapsulated magnetite microparticles 
with hydroxyapatite were fabricated. The encapsulated magnetite microparticles with hydroxyapatite were soaked in 
saline and changes in Fe concentration in saline were measured. Hydroxyapatite encapsulating magnetite 
microparticles inhibited elution of Fe from magnetite. 
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1. Introduction 
Hydroxyapatite (Ca10(PO4)6(OH)2) is a main inorganic component of our bone and has attracted much 
attention as a biomaterial with high bioaffinity. It has high affinity to living bone [1-4] and cells [5,6] and 
an ability to absorb biopolymer such as protein [7]. From these properties, hydroxyapatite is considered as 
one of the most important biomaterials. 
In living body, most of artificial materials are covered with fibrous tissue by an immune reaction of 
living body and isolated from surrounding tissue [8]. However, hydroxyapatite forms bonelike apatite 
layer on their surface in living body [9,10]. As a result, hydroxyapatite can avoid the immune reaction 
and tightly bond to the surrounding living bone thorough this bonelike apatite layer. 
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Kokubo et al. invented a simulated body fluid (SBF) with ion concentrations nearly equal to those of 
human blood plasma [11-13]. It became possible to reproduce the reaction of bonelike apatite formation 
in living body. Kokubo, Yao and Tanahashi applied the biomimetic reaction in SBF and formed 
hydroxyapatite thin film on the surface of various kinds of substrates [14-20]. 
When the pH or the temperature of SBF is raised, fine particles of calcium phosphate are precipitated. 
Recently, we discovered that the fine particle actively induces hydroxyapatite either in SBF or in body 
fluid and we named the particle Apatite Nucleus [21]. 
We presented that hydroxyapatite microcapsules can be fabricated by using biomimetic method 
[22,23]. The method is as follows. For the first process, Apatite Nuclei are attached to the surfaces of 
microparticles. For the second process, the microparticles are soaked in SBF. By this treatment, 
hydroxyapatite is induced from the Apatite Nuclei and grows over the whole surface area of the 
microparticles. As a result, hydroxyapatite is coated on the whole surface of the microparticles and 
hydroxyapatite microcapsules can be obtained. By this method, it is expected to encapsulate various kinds 
of microparticles with hydroxyapatite. 
In the previous studies, by using Apatite Nuclei, we fabricated hollow hydroxyapatite microcapsules 
[24], encapsulated silicagel microspheres with hydroxyapatite [25] and hydroxyapatite microcapsules 
containing insulin in silicagel microspheres [26]. The hydroxyapatite microcapsules possess high 
bioaffinity and are thought to be useful to drug delivery systems. For the hydroxyapatite microcapsules 
containing insulin in silicagel microspheres, sustained-release of insulin was achieved. 
Hyperthermia is one of the most attractive methods for cancer therapy which can selectively heat in 
tumors and kill cancer cells with minimum damage to surrounding normal tissue. Magnetite is a typical 
ferrimagnetic material and is thought to be useful to cancer hyperthermia [27]. Hydroxyapatite 
microcapsules are thought to be able to provide bioactivity to ferrimagnetic materials and useful to 
hyperthermia for bone cancer. 
In the present study, we encapsulated magnetite microparticle with hydroxyapatite by biomimetic 
method using Apatite Nuclei. 
2. Materials and Methods 
2.1. Preparation of SBF 
SBF was prepared by dissolving reagent-grade sodium chloride (NaCl: Wako Pure Chemical 
Industries, Japan), sodium hydrogen carbonate (NaHCO3: Hayashi Pure Chemical Ind., Japan), potassium 
chloride (KCl: Hayashi Pure Chemical Ind., Japan), di-potassium hydrogen phosphate trihydrate 
(K2HPO4·3H2O: Nacalai Tesque, Japan), magnesium chloride hexahydrate (MgCl2·6H2O: Hayashi Pure 
Chemical Ind., Japan), calcium chloride (CaCl2: Hayashi Pure Chemical Ind., Japan) and sodium sulfate 
(Na2SO4: Hayashi Pure Chemical Ind., Japan) in ultrapure water with the composition as shown in Table 
1 and buffered at pH 7.40 with tris(hydroxymethyl)aminomethane ((CH2OH)3CNH2: Hayashi Pure 
Chemical Ind., Japan) and 1 mol·dm-3 hydrochloric acid (HCl: Hayashi Pure Chemical Ind., Japan) at 
36.5 °C. 
2.2. Precipitation of Apatite Nuclei 
The pH of SBF was raised to pH 8.60 by dissolving (CH2OH)3CNH2 at 25.0 °C. By this treatment, we 
precipitated Apatite Nuclei in the SBF. Apatite Nuclei  were collected by filtration using a 
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Table 1. Ion concentrations of simulated body fluid (SBF) and human blood plasma. 
㻌  㻌 Ion concentration / mM  
㻌  㻌 SBF  Blood plasma  
NaCl 142.0 142.0 
NaHCO3 5.0 5.0 
KCl  2.5 2.5 
K2HPO4·3H2O 1.5 1.5 
MgCl2·6H2O 147.8 103.0 
1 M HCl 4.2 27.0 
CaCl2 1.0 1.0 
Na2SO4 0.5 0.5 
 
polytetrafluoroethylene membrane filter with 50 nm for average pore size  (Millipore, USA), washed with 
distilled water, and dried at 36.5 °C. Apatite Nuclei were dispersed in ultrapure water with ultrasonic 
vibration, and Apatite Nuclei-dispersed solution was obtained. 
2.3. Preparation of encapsulated magnetite microparticles with hydroxyapatite 
1 mg of commercially obtained magnetite microparticles (Kojundo Chemical Laboratory, Japan) were 
soaked in the Apatite Nuclei-dispersed solution mentioned above and dispersed with ultrasonic vibration. 
By this treatment, Apatite Nuclei were attached to the surface of the magnetite microparticles. The 
magnetite microparticles were collected by filtration. These magnetite microparticles were soaked in SBF 
at pH 7.40 at 36.5 °C for 7 d. After that, the magnetite microparticles were collected by filtration, washed 
with ultrapure water, and dried at 36.5 °C. 
2.4. Observation of  the microparticles 
Thus obtained magnetite microparticles were analyzed by scanning electron microscopy (SEM: 
ESEM-2700, Nikon, Japan) and energy dispersive X-ray analysis (EDX: DX-4, EDAX International, 
USA). In SEM observation, we conducted Au sputtering on the surface of the specimen. For the reference, 
the not-encapsulated magnetite microparticles were also analyzed by SEM and EDX. 
2.5. Evaluation of Fe elution 
1 mg of the encapsulated magnetite microparticles with hydroxyapatite were soaked in 10 cm3 saline 
(0.01 mol·dm-3 phosphate buffered saline, pH at 25 °C: 7.2-7.4, Wako Pure Chemical Industries, Japan). 
The saline was continued to shake by using shaking apparatus for up to 168 h in an incubator held at 36.5 
°C. Changes in Fe concentration in saline were measured by inductively coupled plasma atomic emission 
spectroscopy (ICP: ICPS-7500, Shimadzu, Japan). For the reference, not-encapsulated magnetite 
microparticles were also dispersed in saline and conducted the same measurement. 
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3. Results and Discussion 
3.1. Observation of the encapsulated magnetite microparticles with hydroxyapatite 
Fig. 1 shows (a) SEM micrograph and (b) EDX profile of the not-encapsulated magnetite 
microparticles. In Fig. 1(a), it was observed that the not-encapsulated magnetite microparticles was about 
300 nm in particle size. In Fig. 1(b), no peak other than Fe and O due to magnetite except C due to a 
carbon tape and Au due to gold sputtering in SEM observation process was detected. 
Fig. 2(a) shows SEM micrograph of the magnetite microparticle soaked in the Apatite Nuclei-
dispersed solution, and then soaked in SBF for 7 d of low magnification. In SEM observation, many 
magnetite microparticles were encapsulated with hydroxyapatite were observed. Fig. 2 (b) shows EDX 
profile of the magnetite microparticles shown in Fig. 2(a). Peaks of phosphorous (P) and calcium (Ca), 
constituents of hydroxyapatite, were detected on the surface. Also, a peak of Fe, constituents of magnetite, 
was also observed. These results indicate that this method has high reproducibility. 
Fig. 3 shows (a) picture of a microcapsule by magnification and (b) EDX profile of the magnetite 
microparticles soaked in the Apatite Nuclei-dispersed solution, and then soaked in SBF for 7 d. In Fig. 
3(a), it was observed that needle-like crystallites characteristic to hydroxyapatite coated whole surface of 
the magnetite microparticles. In Fig. 3(b), peaks of P and Ca, constituents of hydroxyapatite, were 
detected on the surface. Also, a peak of Fe, constituents of magnetite, was also observed. These results 
indicate that hydroxyapatite was induced from the Apatite Nuclei attached to the surface of the magnetite 
microparticles and spread over whole surface area of the magnetite microparticles in SBF. 
3.2. Fe elution in saline 
Fig. 4 shows cumulative elution of Fe from encapsulated magnetite microparticles with hydroxyapatite 
and not-encapsulated magnetite microparticles in saline up to 168 h at 36.5 °C. In Fig. 4, (a), solid circle 
and full line, shows the change in elution ratio of Fe for the encapsulated magnetite microparticles and (b), 
open circle and dotted line, shows that for the not-encapsulated ones. The elution ratio of Fe was 
calculated by dividing the weight of Fe eluted from magnetite microparticles in saline measured by ICP 
by that contained in magnetite microparticles soaked in the saline. The elution ratio of Fe for the 
 
Fig. 1. (a) SEM micrograph and (b) EDX profile of the not-encapsulated magnetite microparticles. 
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Fig. 2. (a) SEM micrograph of low magnification and (b) EDX profile of the magnetite microparticles soaked in Apatite Nuclei 
dispersed-solution, and then soaked in SBF for 7 d. 
 
Fig. 3. (a) SEM micrograph and (b) EDX profile of the magnetite microparticles soaked in Apatite Nuclei dispersed-solution, and 
then soaked in SBF for 7 d. 
encapsulated magnetite microparticles with hydroxyapatite was approximately one over ten of that for 
not-encapsulated ones. This result indicates that hydroxyapatite encapsulating magnetite microparticles 
inhibit elution of Fe from magnetite. 
4. Conclusion 
When the pH or the temperature of SBF is raised, fine particles of calcium phosphate are precipitated 
in the fluid. We found that these particles are very active for forming hydroxyapatite from SBF and we 
named this particle Apatite Nucleus. 
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Fig. 4. Cumulative elution of Fe from (a) encapsulated magnetite microparticles with hydroxyapatite (solid circle and full line) and 
(b) not-encapsulated magnetite microparticles (open circle and dotted line) in saline up to 168 h at 36.5 °C. 
We have successfully fabricated encapsulated magnetite microparticles with hydroxyapatite by 
biomimetic method. Apatite Nuclei were synthesized by raising pH of SBF. Hydroxyapatite was formed  
from Apatite Nuclei attached on the magnetite microparticles by soaking in SBF, and then the 
encapsulated magnetite microparticles with hydroxyapatite were obtained. Hydroxyapatite encapsulating 
magnetite microparticles inhibit elution of Fe from magnetite. Application of this material is promising 
for cancer hyperthermia. 
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